| |
| |
|
| Insider
Information: |
Leung Sandra |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
348,885 |
|
|
Indirect Shares
|
100,721 |
|
|
| Direct
Value |
$15,653,168 |
|
|
|
Indirect Value
|
$4,538,488 |
|
|
| Total
Shares |
449,606 |
|
|
| Total
Value |
$20,191,656 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 7.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2004-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
3,624 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
4,987 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2005-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,987 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2006-03-07 |
4 |
A |
$22.73 |
$79,782 |
D/D |
3,510 |
14,608 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,875 |
16,727 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
269 |
91,744 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,009 |
101,614 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,357 |
107,911 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,668 |
235,853 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
14,773 |
220,080 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,784 |
262,094 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,214 |
264,334 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,418 |
278,746 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,189 |
304,159 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,631 |
308,072 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,303 |
320,424 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,082 |
324,623 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,431 |
404,322 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,540 |
441,948 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,096 |
591,284 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,554 |
387,579 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,288 |
403,642 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
8,731 |
361,160 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2023-11-21 |
4 |
A |
$48.75 |
$479,163 |
I/I |
9,830 |
93,436 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2009-02-17 |
4 |
B |
$24.00 |
$36,000 |
D/D |
1,500 |
1,500 |
2.39 |
- |
|
133 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
